Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome

Annals of Neurology

Volumn 75, Issue 5, 2014, Pages 771-781

  Claassen, Jan ^a,b   Albers, David ^b   Schmidt, J Michael ^a   De Marchis, Gian Marco ^a   Pugin, Deborah ^a   Falo, Christina Maria ^a   Mayer, Stephan A ^a,b   Cremers, Serge ^b   Agarwal, Sachin ^a,b   Elkind, Mitchell S V ^b,c   Connolly, E Sander ^b   Dukic, Vanja ^d   Hripcsak, George ^b   Badjatia, Neeraj ^a,b  

^a NEUROLOGICAL INSTITUTE   (United States)

^b Comprehensive Epilepsy Center Department of Neurology College of Physi and Surg ^*  (United States)

^c Department of Neurosurgery College of Physi and Surg ^*  (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

brain metabolism; continuous EEG monitoring; electrographic seizures; inflammation; nonconvulsive seizures; subarachnoid hemorrhage

Indexed keywords

C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; ANEURYSM; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN VENTRICULITIS; ELECTROENCEPHALOGRAM; FEMALE; HOSPITAL; HOSPITAL INFECTION; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONCONVULSIVE SEIZURE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SEIZURE; SEPSIS; SUBARACHNOID HEMORRHAGE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY TRACT INFECTION;

BRAIN METABOLISM; CONTINUOUS EEG MONITORING; ELECTROGRAPHIC SEIZURES; INFLAMMATION; NONCONVULSIVE SEIZURES; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; COHORT STUDIES; EPILEPSY, GENERALIZED; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84902264392     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24166     Document Type: Article

References (49)

1. Claassen J, Hirsch LJ, Frontera JA, et al. Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care 2006; 4: 103-112.
2. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17: 3-23.
3. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010; 17: 348-355.
4. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43: 1711-1737.
5. Rossetti AO, Logroscino G, Bromfield EB,. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005; 62: 1698-1702.
6. Zhang S, Wang L, Liu M, Wu B,. Tirilazad for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2010 (2): CD006778.
7. Haley EC Jr, Thompson JL, Levin B, et al. Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies. Stroke 2005; 36: 1006-1010.
8. Rossetti AO, Milligan TA, Vulliemoz S, et al. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011; 14: 4-10.
9. Librizzi L, Noe F, Vezzani A, et al. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 2012; 72: 82-90.
10. Marchi N, Johnson AJ, Puvenna V, et al. Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia 2011; 52: 1627-1634.
11. Loscher W,. Strategies for antiepileptogenesis: antiepileptic drugs versus novel approaches evaluated in post-status epilepticus models of temporal lobe epilepsy. In:, Noebels JL, Avoli M, Rogawski MA, et al, eds. Jasper's basic mechanisms of the epilepsies. 4th ed. Bethesda, MD: National Center for Biotechnology Information, 2012. Available at: http://www.ncbi.nlm.nih.gov/ books/NBK98148/.
12. Hanafy KA, Grobelny B, Fernandez L, et al. Brain interstitial fluid TNF-alpha after subarachnoid hemorrhage. J Neurol Sci 2010; 291: 69-73.
13. Badjatia N, Carpenter A, Fernandez L, et al. Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 2011; 42: 2436-2442.
14. Hutchinson PJ, O'Connell MT, Rothwell NJ, et al. Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma 2007; 24: 1545-1557.
15. Sarrafzadeh A, Schlenk F, Gericke C, Vajkoczy P,. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2010; 13: 339-346.
16. Sutter R, Grize L, Fuhr P, et al. Acute-phase proteins and mortality in status epilepticus: a 5-year observational cohort study. Crit Care Med 2013; 41: 1526-1533.
17. Riazi K, Galic MA, Kuzmiski JB, et al. Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A 2008; 105: 17151-17156.
18. Marchi N, Fan Q, Ghosh C, et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 2009; 33: 171-181.
19. Claassen J, Perotte A, Albers D, et al. Nonconvulsive seizures after subarachnoid hemorrhage: multimodal detection and outcomes. Ann Neurol 2013; 74: 53-64.
20. Komotar RJ, Schmidt JM, Starke RM, et al. Resuscitation and critical care of poor-grade subarachnoid hemorrhage. Neurosurgery 2009; 64: 397-410; discussion 411.
21. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
22. Pearl J,. Causality: models, reasoning and inference. 2nd ed. New York, NY: Cambridge University Press, 2009.
23. MacKinnon DP, Lockwood CM, Hoffman JM, et al. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002; 7: 83-104.
24. Preacher KJ, Hayes AF,. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 2004; 36: 717-731.
25. Iadecola C, Anrather J,. The immunology of stroke: from mechanisms to translation. Nat Med 2011; 17: 796-808.
26. Shichita T, Hasegawa E, Kimura A, et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med 2012; 18: 911-917.
27. Chen GY, Nunez G,. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826-837.
28. Bernstein LH,. The systemic inflammatory response syndrome C-reactive protein and transthyretin conundrum. Clin Chem Lab Med 2007; 45: 1566-1567; author reply 1568-1569.
29. Pinilla JC, Hayes P, Laverty W, et al. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 1998; 124: 799-805; discussion 806.
30. McCoy MK, Tansey MG,. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 2008; 5: 45.
31. Elkind MS, Cheng J, Boden-Albala B, et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 2002; 33: 31-37.
32. Duncombe AS, Brenner MK,. Is circulating tumor necrosis factor bioactive? N Engl J Med 1988; 319: 1227-1228.
33. Piccinini AM, Midwood KS,. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010; 2010. Available at: http://www.hindawi.com/ journals/mi/2010/672395/cta/.
34. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011; 208: 2581-2590.
35. Vespa PM, McArthur DL, Xu Y, et al. Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurology 2010; 75: 792-798.
36. Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999; 91: 750-760.
37. Alexander JJ, Jacob A, Cunningham P, et al. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int 2008; 52: 447-456.
38. Marchi N, Granata T, Ghosh C, Janigro D,. Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia 2012; 53: 1877-1886.
39. Frigerio F, Frasca A, Weissberg I, et al. Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology. Epilepsia 2012; 53: 1887-1897.
40. Oddo M, Carrera E, Claassen J, et al. Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009; 37: 2051-2056.
41. DeGiorgio CM, Heck CN, Rabinowicz AL, et al. Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology 1999; 52: 746-749.
42. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003; 60: 1441-1446.
43. Vespa PM, Miller C, McArthur D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med 2007; 35: 2830-2836.
44. Vespa P, Prins M, Ronne-Engstrom E, et al. Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. J Neurosurg 1998; 89: 971-982.
45. Yoshimoto Y, Tanaka Y, Hoya K,. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001; 32: 1989-1993.
46. Greenhalgh AD, Brough D, Robinson EM, et al. Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis Model Mech 2012; 5: 823-833.
47. Furuya K, Takeda H, Azhar S, et al. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 2001; 32: 2665-2674.
48. Ziv Y, Finkelstein A, Geffen Y, et al. A novel immune-based therapy for stroke induces neuroprotection and supports neurogenesis. Stroke 2007; 38 (2 suppl): 774-782.
49. Rossato M, Curtale G, Tamassia N, et al. IL-10-induced microRNA-187 negatively regulates TNF-alpha, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc Natl Acad Sci U S A 2012; 109: E3101-E3110.